Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

bryant ranch prepack - clindamycin palmitate hydrochloride (unii: vn9a8jm7m7) (clindamycin - unii:3u02el437c) - clindamycin palmitate hydrochloride for oral solution, usp (pediatric) (clindamycin palmitate hcl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). anaerobes: serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection. streptococci: serious respiratory tract infections; serious skin and soft tissue infections. staphylococci: serious respiratory tract infections; serious skin and soft tissue infections. pneumococci: serious respiratory tract infections. bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin palmitate hydrochloride for oral solution (pediatric) and other antibacterial drugs, clindamycin palmitate hydrochloride for oral solution (pediatric) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

jmac (wa) pty ltd trading as pharmaust manufacturing - ipecacuanha powder -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 34893 - cannula, arterial - pediatric arterial cannulae used in cardiopulmonary bypass surgery. intended for use in perfusion of the ascending aorta during cardiopulmonary bypass.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 45966 - pacing lead, external, transthoracic, temporary - temporary pacing lead intended for temporary atrial and ventricular pacing and sensing for a contemplated implant duration of 7 days or less.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 47635 - craniofacial bone distractor - intended to be used for bone stabilization and lengthening of the mandibular body and ramus in neonates and children up to 4 years old.

Canada - Tiếng Anh - Health Canada

sandoz canada incorporated - digoxin - liquid - 0.05mg - digoxin 0.05mg - cardiotonic agents